Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262860
Status:
COMPLETED
Last Update Posted:
2016-05-09
First Post:
2005-12-06
Brief Title:
Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkins Lymphoma
Sponsor:
University of Rochester
Organization:
University of Rochester
Organization Data
Organization:
University of Rochester
Class:
OTHER
Study ID:
CDR0000448635
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Rochester
Lead Sponsor Class:
OTHER
Responsible Party:
Jonathan Friedberg
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Rochester
Old Name:
None
Old Organization:
None